The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
What Is The Estimated Market Size Of The Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market In 2026, And How Will Its Value Evolve By 2030?
The artificial intelligence (AI)-powered chronic heart failure digital coach market has experienced significant expansion in recent years. Its valuation is set to increase from $1.93 billion in 2025 to $2.48 billion in 2026, reflecting a compound annual growth rate (CAGR) of 28.3%. The market’s past growth was driven by factors such as increasing incidence of heart failure, expansion of remote patient monitoring adoption, rising healthcare digitization, growing availability of connected medical devices, and increasing focus on preventive cardiac care.
The market size for artificial intelligence (AI)-powered chronic heart failure digital coaches is anticipated to experience significant expansion over the coming years, projected to reach $6.64 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 28.0%. This growth during the forecast period is driven by advancements in AI-powered clinical analytics, the increasing adoption of personalized care management, the expansion of home-based cardiac monitoring, rising investments in digital cardiology platforms, and a growing demand for continuous patient engagement solutions. Notable trends for the forecast period include the increasing deployment of AI-based cardiac monitoring coaches, growing integration with wearable heart sensors, the rising use of predictive health analytics, the expansion of remote chronic care platforms, and an enhanced focus on patient self-management tools.
Access Your Free Sample Report For In-Depth Market Analysis:
Which Important Drivers Are Guiding The Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Growth?
The escalating challenge posed by cardiovascular diseases is anticipated to spur the advancement of the artificial intelligence (AI)-powered chronic heart failure digital coach market. These diseases encompass a range of heart and blood vessel disorders, including coronary heart disease, cerebrovascular disease, and other conditions affecting the circulatory system. The prevalence of cardiovascular diseases is increasing, as diets high in processed foods and salt elevate blood pressure and cholesterol, thereby heightening the risk of heart ailments. An artificial intelligence (AI)-powered chronic heart failure digital coach assists in managing cardiovascular diseases through real-time health monitoring, personalized guidance on medications and lifestyle, and by enabling the early detection of complications for proactive care. For instance, in October 2024, the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, reported that 919,032 people in the United States died from cardiovascular disease in 2023, accounting for approximately one in every three deaths nationwide. Thus, the increasing burden of cardiovascular diseases is propelling the growth of the artificial intelligence (AI)-powered chronic heart failure digital coach market.
Which Segment Categories Are Included In The Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Segment Analysis?
The artificial intelligence (AI)-powered chronic heart failure digital coach market covered in this report is segmented –
1) By Component: Software, Hardware, Services
2) By Deployment Mode: Cloud-Based, On-Premises
3) By Application: Remote Patient Monitoring, Personalized Care Management, Medication Adherence, Patient Education, Other Applications
4) By End-User: Hospitals And Clinics, Homecare Settings, Research And Academic Institutes, Other End-Users
Subsegments:
1) By Software: Cloud-Based Platforms, Mobile Applications, Data Analytics Tools, Patient Monitoring Dashboards, Integration Middleware
2) By Hardware: Wearable Devices, Smart Sensors, Connected Medical Devices, Home Monitoring Equipment, Edge Computing Devices
3) By Services: Implementation And Integration Services, Consulting Services, Maintenance And Support Services, Training And Education Services, Remote Patient Monitoring Services
What Trends Are Influencing The Evolution Of The Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market?
Major companies operating in the artificial intelligence (AI)-powered chronic heart failure digital coach market are prioritizing the development of at-home monitoring solutions, such as non-invasive heart failure management platforms, to boost medication adherence and enable proactive disease management. Non-invasive heart failure management platforms are digital tools designed to track heart function and patient vitals without surgery, utilizing sensors, wearables, and AI analytics to monitor symptoms and guide therapy for prompt intervention and improved disease management. For instance, in September 2024, Astellas Pharma Inc., a Japan-based pharmaceutical company, introduced DIGITIVA, a novel non-invasive digital health solution for heart failure management, following its Food and Drug Administration (FDA) listing. This solution enables at-home disease monitoring and is designed to center care around patients, incorporating the CORE 500 Digital Stethoscope, a smartphone app built on Welldoc’s platform, educational content from the American Heart Association, and a dedicated clinical review team to aid in early intervention and enhance clinical outcomes, such as reducing acute events and hospitalizations.
Who Are The Active Companies Shaping The Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market?
Major companies operating in the artificial intelligence (AI)-powered chronic heart failure digital coach market are Koninklijke Philips N.V., Boston Scientific Corporation, Astellas Pharma Inc., Best Buy Health Inc., Tempus AI Inc., Biofourmis Inc., Athelas Inc., Hello Heart Inc., Huma Therapeutics Limited, Welldoc Inc., Cleerly Inc., Cadence Solutions Inc., Lark Health Inc., One Drop, Binah.ai Ltd., Xealth Inc., Nanowear Inc., Cordio Medical Ltd., Kento Health Inc., my mhealth Limited, Implicity SAS.
Get The Full Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Report:
Which Region Accounts For The Largest Portion Of The Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market?
North America was the largest region in the artificial intelligence (AI)-powered chronic heart failure digital coach market in 2025. The regions covered in the artificial intelligence (AI)-powered chronic heart failure digital coach market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market Report For Competitive Insights:
Browse Through More Reports Similar to the Global Artificial Intelligence (AI)-Powered Chronic Heart Failure Digital Coach Market 2026, By The Business Research Company
Artificial Intelligence Ai Studio Market Report 2026
Cardiac Ai Monitoring And Diagnostics Market Report 2026
Ai In Medical Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/ai-in-medical-devices-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model